Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Vir Biotechnology, Inc.
Business Segments
Business Segments
Business Segments
10 metrics
Clinical costs
Contract manufacturing
Licenses, collaborations and contingent consideration, net
Net loss
Other R&D
Personnel
Plus: Other segment items
Restructuring, long-lived assets impairment and related charges, net
SG&A
Total revenues